Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A Comment authored by experts at the University of Oxford is published in The Lancet Child and Adolescent Health, highlighting specific developmental principles that should guide conversations with children about COVID-19.

These specific developmental principles include:

  • Children's need for honest information about changes within their family; when this is absent they attempt to make sense of the situation on their own
  • Consideration of children's developmental stage helps to make communication more effective
  • Communication with young children should not just rely on simplifying language or concepts, but take into account children's comprehension of illness and causality

Research shows that sensitive and effective communication about life threatening illness has major benefits for children and their family’s long-term psychological wellbeing.

 

In this rapidly changing situation, media and social conversations are entirely dominated by the coronavirus and children are being exposed to large amounts of information and high levels of stress and anxiety in the adults around them. This is occurring at a time when children are also experiencing significant changes to their daily routine, and contact with friends and grandparents, which are often key to children's resilience. - Professor Alan Stein, Department of Psychiatry, University of Oxford.

 

It is unconscionable to ignore the immediate and longer-term psychological impact of this global situation, especially for children and young people who account for 42% of our world's population.

Parents would do anything to protect their children from distress and consequently may avoid talking about difficult feelings and events. However, research shows that even very young children are aware of things changing around them and that their understanding evolves throughout childhood and adolescence.

This Comment highlights some important concepts to help parents and care givers communicate with children:

  • Magical thinking - a concept that describes a child's belief that thoughts, wishes or unrelated actions can cause external events; for example that an illness can be caused by a particular thought or behaviour (e.g. "Daddy got sick because I was naughty and didn't go to bed nicely.")

  • Adults' preoccupation with the financial, practical and emotional impact of COVID-19 may compromise their ability to sensitively recognise and respond to signs of children's worries and distress
  • Adults need to provide a model of sharing some of their worries, without overwhelming children with their own distress

Prioritising effective communication with children about COVID-19 is an essential component of a universal, community-led response to the pandemic to protect the intermediate and long-term psychological wellbeing of children.

Read the full Comment published in The Lancet Child and Adolescent Health.

The team, led by Dr Louise Dalton and Dr Elizabeth Rapa, has developed resources:

  • To guide healthcare workers who need to inform families by telephone that a relative has died of COVID-19. A key part of this is to identify if the deceased was a parent. Contacting Relatives by Phone to Communicate the Death of a Patient 
  • To support caregivers with the unenviable task of telling children of an adult’s death (e.g. parent or grandparent) How to Tell Children that Someone has Died. In the forthcoming weeks, this guidance will be personalised to specific disciplines which are moving to telemedicine rather than face-to-face consultations.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Improving Experiences of People with Serious Mental Health Problems

Mental Health

A project led by Professor Kam Bhui and Dr Roisin Mooney, University of Oxford, will focus on reducing the number of people admitted or readmitted to compulsory care under the Mental Health Act. This is one of four new research projects funded by the National Institute for Health Research (NIHR) with the aim to improve patient experiences and outcomes under the Mental Health Act.

Just Over Half of British Indians Would Get COVID Vaccine

COVID-19 Mental Health

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

Mental Health Schizophrenia

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental Mental Health Worse Since New National Restrictions

COVID-19 Child and adolescent Early intervention Mental Health Psychological therapy

Parental stress, depression, and anxiety have again increased since new national restrictions have been introduced according to the latest report from the Oxford University led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study based on data from over 6000 UK parents.

Potential New Target to Prevent or Delay Dementia

Alzheimer's disease Dementia Mental Health Old-age psychiatry

New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.

Over One Quarter of UK Population are Hesitant about COVID-19 Vaccination

COVID-19

The most comprehensive study of COVID-19 vaccine hesitancy to date shows a majority willing to be vaccinated, but a substantial minority concerned. Researchers from the University of Oxford surveyed a representative group of 5,114 UK adults about an approved COVID-19 vaccine for the NHS.